top of page
Prilenia Neurotherapeutics
Develops treatments for neurodegenerative and neurodevelopmental disorders, with a focus on pridopidine for Huntington's disease and ALS, currently in late-stage clinical trials.
Company Name | Neurotech Category | Market Category | Company Founded Year | Company Location |
|---|---|---|---|---|
Prilenia Neurotherapeutics | NeuroPharmacology | NeuroBioTechnology | Biotechnology & Biopharmaceutical | 2018 | Herzliya |
Develops treatments for neurodegenerative and neurodevelopmental disorders, with a focus on pridopidine for Huntington's disease and ALS, currently in late-stage clinical trials.
bottom of page